Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2021-09-23 00:00:00 ET · period of report 2021-09-17 · accession 0001209191-21-057470 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-23 | 2021-09-17 | BDTX | Behbahani Ali | Dir | A - Grant | $9.90 | +1,326 | 2,887 | +85% | +$13.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-17 | A | A | 1,326 | $9.90 | 2,887 | D | — | — | (F2) The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on September 16, 2021. |